You just read:

Phase III Results: Once-daily Tiotropium* Effective in Symptomatic Asthma Patients Irrespective of Their Age, Allergic Status, Smoking Status and Bronchodilator Response

News provided by

Boehringer Ingelheim

21 May, 2013, 14:07 BST